代谢组学在结直肠癌诊断中的应用

doi:10.11904/j.issn.1002-3070.2017.06.018

Abstract

Abstract: Colorectal cancer,a common malignant tumor,is a serious threat to human health.Metabolomics can effectively solve the shortcomings of the traditional ways of inspection.Metabolomics develop different metabolites to find new specific tumor markers by detecting metabolites in tissues,blood and urine of cancer patients.Compared with normal cells,tumor cells exist a number of abnormal metabolic pathways.It lays the foundation for further study of biomarkers of colorectal cancer by finding out its metabolic changes.It also shows important significance for diagnosis,evaluation of efficacy and prognosis and individual treatment.

Key words: Colorectal cancer, Diagnosis, Metabolomics, miRNA

CLC Number:

R735.3⁺4

ZHANG Shanshan, WU Huaxing. Aplication of metabolomics in the diagnosis of colorectal cancer[J]. PRACTICAL ONCOLOGY JOURNAL, 2017, 31(6): 573-576.

References

1 胡正青,林夏珍,郭明.代谢组学研究技术进展[J].中国现代应用药学,2010,27(6):485-490.
2 Garritano S,Selvaggi F,Spampinato MG.Simultaneous minimally invasive treatment of colorectal neoplasm with synchronous liver metastasis[J].Med Sci,2016,6(6):1-7.
3 Esposito K,Chiodini P,Colao A,et al.Metabolic syndrome and risk of cancer[J].Diabetes Care,2012,35(11):2402-2411.
4 Di L M,Travaglio E,Altomare DF.New strategies for colorectal cancer screening[J].World J Gastroenterol,2013,19(12):1855-1860.
5 Zhang A,Sun H,Yan G,et al.Metabolomics in diagnosis and biomarker discovery of colorectal cancer[J].Cancer Letters,2014,345(1):17-21.
6 戚文娟,田雪娇,周长江.代谢组学在结直肠癌中的研究进展[J].医学与哲学,2013,34(12):62-64.
7 Huang S,Chong N,Lewis NE,et al.Novel personalized pathway-based metabolomics models reveal key metabolic pathways for breast cancer diagnosis[J].Genome Medicine,2016,8(1):554-561.
8 Whiteside TL.The tumor microenvironment and its role in promoting tumor growth[J].Oncogene,2008,27(45):5904-5912.
9 吴卉,花荣,陈锦先.代谢组学在结直肠肿瘤中的应用进展[J].胃肠病学,2010,15(8):499-501.
10 Ludwig C,Ward DG,Martin A,et al.Fast targeted multidimensional NMR metabolomics of colorectal cancer[J].Magn Reson Chem,2010,47(1):68-73.
11 Yuan T,Xu T,Huang J,et al.Tissue metabonomic phenotyping for diagnosis and prognosis of human colorectal cancer[J].Scientific Reports,2016,6(4):188-196.
12 Schipani E,Maes C,Carmeliet G,et al.Regulation of osteogenesis-angiogenesis coupling by HIFs and VEGF[J].J Bone Miner Res,2009,24(8):1347-1353.
13 Montrose DC,Zhou XK,Kopelovich L,et al.Metabolic profiling,a noninvasive approach for the detection of experimental colorectal neoplasia[J].Cancer Prevention Research,2012,5(12):1358-1367.
14 Denkert C,Budczies J,Weichert W,et al.Metabolite profiling of human colon carcinoma-deregulation of TCA cycle and amino acid turnover[J].Molecular Cancer,2008,7(1):72-87.
15 Kühn T,Floegel A,Sookthai D,et al.Higher plasma levels of lysophosphatidylcholine 18:0 are related to a lower risk of common cancers in a prospective metabolomics study[J].BMC Medicine,2016,14(1):1-9.
16 Ke J,Lin Y,Ruge F,et al.Implication of metastasis suppressor gene,Kiss-1 and its receptor Kiss-1R in colorectal cancer[J].BMC Cancer,2014,14(1):723-734.
17 Wang Y,Hu Z,Liang J,et al.A tandem repeat of human telomerase reverse transcriptase(hTERT)and risk of breast cancer development and metastasis in Chinese women[J].Carcinogenesis,2008,29(6):1197-1201.
18 Gertler R,Rosenberg R,Stricker D,et al.Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma[J].Med Sci,2004,22(10):1807-1814.
19 伍世钢.hTERT和E2F-1蛋白在结直肠癌组织中的表达及其临床意义[D].广州:暨南大学,2016.
20 Urayama S.Pancreatic cancer early detection:Expanding higher-risk group with clinical and metabolomics parameters[J].World J Gastroenterol,2015,21(6):1707-1717.
21 王健.miR-552和miR-592在结直肠肿瘤中表达的研究[D].宁夏:宁夏医科大学,2015.
22 Alexander L,Francesc B,Shen Y,et al.Fecal microRNAs as novel biomarkers for colon cancer screening[J].Cancer Epidemiol Biomarkers Prev,2010,19(7):1766-1774.
23 杨静.检测粪便脱落细胞中miR-135b表达筛查结直肠进展期腺瘤及TNMⅠ期Ⅱ期癌的意义研究[D].太原:山西医科大学,2016.
24 徐学虎,黎淑玲,吴小兵,等.miR-4770作为结直肠癌的诊断标志物研究[J].实用医学杂志,2015,31(18):2994-2997.
25 靳慧芳.miR-30a对结直肠癌细胞侵袭和转移的影响及其相关分子机制的初步研究[D].郑州:郑州大学,2015.

[1]	LV Bowen, QIAN Jun, WANG Jie, QIAN Jingrong, LU Yingying, SU Liju, YANG Tongshu, LI Wenhui. Expression of MiR-455-5p in epithelial ovarian cancer and its target gene function [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 115-121.
[2]	SUN Jianghong, HAO Mingzhu, JIANG Dan, GUO Fei, LI Xiaomei. FFDM differential diagnosis of mastitis,benign hyperplasia and breast cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 139-141.
[3]	FANG Lin, LIU Chao, ZHANG Chunhui, ZHANG Yanqiao. Research status and treatment strategies of maintenance therapy for metastatic colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 173-178.
[4]	TONG Guanghai, TIAN Yang, WU Huaxing. Application of lipidomics in colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 179-192.
[5]	LIU Hengchen, ZHANG Xinyu. Toll-like receptor signaling pathway as a potential therapeutic target for colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2019, 33(2): 188-192.
[6]	TIAN Yang, WU Huaxing. Clinical application of ultra-fine nasal endoscopy in digestive tract stenosis [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(6): 550-554.
[7]	WANG Peng, ZHOU Haitao, LIANG Jianwei, ZHOU Zhixiang. Misdiagnosis of mesenteric fibromatosis as recurrence after radical resection of rectal cancer:A report of one case with literature review [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 442-444.
[8]	LIU Hongtao, ZHANG Tongtong, LIU Yanjun. Research progress in the pathogenesis of obesity and colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(5): 464-467.
[9]	WANG Zhi,LIU Zhongwei,ZENG Xueyun,SUI Mingjie,LIAO Jingyi,LI Yuehuan,HUANG Weidong,LIU Guoxiang. Health-related quality of life in patients with colorectal cancer precancerous lesions on EQ-5D-5L [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 320-326.
[10]	FANG Zhenjian,WU Zhengcong,ZHENG Hongzong,AO Riying,LAI Guoxiang. Diagnostic value of CT enhancement for solitary pulmonary nodules of different size [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 333-336.
[11]	LI Hongwei,JIANG Xiaofeng,CHEN Song,BIE Yifei,DU Yong. A case of huge scar squamous cell carcinoma with skull and dural invasion [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 337-339.
[12]	CUI Xueyang,XING Chengzhong. The research and application of liquid biopsy in the field of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 367-370.
[13]	LI Wenqi,GENG Jingshu. Research progress of RAS,RAF mutation and MSI status in the treatment of colorectal cancer [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(4): 371-376.
[14]	LV Qiang, CHEN Hongsheng, LI Guodong, WEI Jiufeng, LIU Ming. Effects of tumor-associated fibroblasts in the development of colorectal cancer and its research progress [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(3): 275-279.
[15]	MIAO Suping, GUO Erliang, PEI Rong, JIANG Huanyu, MIAO Susheng. Research progress in miRNA regulatory immune checkpoint in cancer therapy [J]. PRACTICAL ONCOLOGY JOURNAL, 2018, 32(1): 57-62.

Aplication of metabolomics in the diagnosis of colorectal cancer

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments